# Azora Therapeutics, Inc. (DE): Form DEF 14A, filed Jan 6, 2026

- Company: [Azora Therapeutics, Inc. (DE)](/companies/adil.md) (CIK 1513525)
- Form: DEF 14A
- Filed: 2026-01-06
- Accepted by EDGAR: Jan 6, 2026, 16:15 ET
- Period: 2026-02-26
- Accession: 0001213900-26-001792
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1513525/000121390026001792/ea0270782-def14a_adialpharma.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1513525/000121390026001792/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1513525/000121390026001792/ea0270782-def14a_adialpharma.htm

Filed Jan 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-001792. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
